TLR4 expression was also reduced in patients with advanced stages of B-CLL, as well as in patients with the expression of ZAP-70 and CD38, which are unfavorable prognostic factors in B-CLL. The gene discussed is TLR4; the disease is B-cell chronic lymphocytic leukemia.